Global Cancer Biological Therapy Market : Global Market Size, Trends, Competitive, Historical & Forecast Analysis, 2019-2025

Report ID: BMRC 318 | Number of pages: 192 | Publish Date: Aug 2019 | Publisher: BMRC | Category: Lifesciences and Healthcare
Global Cancer Biological Therapy market is valued at USD 43.60 Billion in 2018 and expected to reach USD 59.9 Billion by 2025 with the CAGR of 5.5 % over the forecast period. Increasing Demand for advanced therapies like biological medical aid and growth of cancer aid facilities in emerging countries is anticipated to grow cancer biological therapy market.	

Biological therapy is designed to stimulate or restore the ability of the body's immune system to fight infection and disease. Some biological therapies stimulate or suppress the immune system to fight with cancer, infection, and other diseases. Biological therapy also target specific molecules on cancer cells to destroy the damaged cells, or it may target proteins that facilitate the growth of cancer cells.  Using modern laboratory techniques, scientists can produce BRMs in huge extents for use in the treatment of cancer and other diseases, such as rheumatoid arthritis and Crohn's disease. 

Biological therapy for cancer is used in the treatment of numerous types of cancer to prevent or slow tumor growth and to prevent the spread of cancer. Monoclonal antibodies are a common type of biological therapy for many different cancers and further conditions. These are laboratory-produced antibodies that are considered to attack specific proteins expressed by abnormal cells. Examples of antibody medication embody rituximab that is employed to treat non-Hodgkin's cancer, alemtuzumab (Campath) to treat chronic leucaemia (CLL), and ipilimumab (Yervoy) for pathologic process malignant melanoma. 

Global cancer biological therapy market report is segmented on the basis of type, application, and regional & country level. Based upon type, cancer biological therapy market is classified as vaccines, cancer growth blockers, monoclonal antibodies, cytokines, gene therapy and blood cell growth factors. Based upon application, cancer biological therapy market is classified into, hospital pharmacies, retail pharmacies and mail order pharmacies.

The regions covered in this global cancer biological therapy market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of Cancer Biological Therapy is sub divided into U.S., Mexico, Canada, UK, France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc. 

Key Players for Global Cancer Biological Therapy Market Reports:
Global cancer biological therapy market report covers prominent players are like F. Hoffmann-La Roche AG, Novartis International AG, Merck & Co., Inc., Amgen Inc., GlaxoSmithKline Plc, Bristol-Myers Squibb, Eli Lilly, Spectrum Pharmaceuticals, Inc., Seattle Genetics, Inc., Celgene Corporation and Others 

Increasing Demand for advanced therapies like biological medical aid and growth of cancer aid facilities in emerging countries is anticipated to grow cancer biological therapy Market.: Demand for advanced therapies is increasing which are demanded by patients with the intent of treating some incurable conditions. In recent decades, genes, cells and tissues have been adapted as new therapeutic tools in medicine. In this new approach, known as advanced therapies, each of these therapeutic agents is termed as advanced therapy medicinal product such as drugs, devices and biological agents, products based on genes, cells and tissues are subject to regulatory requirements that vary widely among countries and product types. The regulatory requirements for ATMPs were established in the European Union by two European Directives and by EC Regulation. 

Example of this Radiation therapy is a cancer treatment that uses high doses of radiation to kill cancer cells and shrink tumors. At low doses, radiation is employed in x-rays to check within your body, like x-rays of your teeth or broken bones. Growing geriatric population can drive cancer biological medical care trade growth throughout forecast timeframe. Improving the evaluation of new cancer treatments is an opportunity for cancer biological therapy market. Negative influence on clinical outcome hampers the growth of market.

North America is dominating the Cancer Biological Therapy Market: Growth among the North American region is primarily driven by presence of huge variety of cancer biological drug and immunogenic manufacturers, increasing disposable income, affordable cancer treatment facility and growing number of health insurance coverage for life-threatening diseases. In Asia, the growth of biological therapy is expected to outpace the worldwide average at 60% to 7.1 million cases per year this is further complicated by a rising life expectancy and an aging population in Asia. Previously, the cancer-specific death rate was lower in developing countries such as those in Asian countries, predominantly due to infectious diseases. 

The paradigm faced by the leading economies of the US, Europe and Japan are significantly different from those in the emerging markets of India, China, South America and Russia. According to IMS health, the rising markets of Europe are consecutive major growth drivers for the global pharm industry with more than 40% of incremental growth of the industry coming from emerging economies in the next decade. 

Global Cancer Biological Therapy market Segmentation:

By Type
•	Vaccines
•	Cancer growth blockers
•	Monoclonal antibodies
•	Cytokines
•	Blood cell growth factors
•	Gene therapy

By Application
•	Hospital pharmacies
•	Retail pharmacies
•	Mail order pharmacies

This comprehensive report will provide:
• Enhance your strategic decision making
• Assist with your research, presentations and business plans
• Show which emerging market opportunities to focus on
• Increase your industry knowledge
• Keep you up-to-date with crucial market developments
• Allow you to develop informed growth strategies
• Build your technical insight
• Illustrate trends to exploit
• Strengthen your analysis of competitors
• Provide risk analysis, helping you avoid the pitfalls other companies could make
• Ultimately, help you to maximize profitability for your company.

Our Market Research Solution Provides You Answer to Below Mentioned Question:
• Which are the driving factors responsible for the growth of market?
• Which are the roadblock factors of this market?
• What are the new opportunities, by which market will grow in coming years?
• What are the trends of this market?
• Which are main factors responsible for new product launch?
• How big is the global & regional market in terms of revenue, sales and production?
• How far will the market grow in forecast period in terms of revenue, sales and production?
• Which region is dominating the global market and what are the market shares of each region in the overall market in 2017?
• How will each segment grow over the forecast period and how much revenue will these segment account for in 2025?
• Which region has more opportunities?
Table of Content
1. Chapter - Report Methodology
1.1. Research Process 
1.2. Primary Research 
1.3. Secondary Research
1.4. Market Size Estimates
1.5. Data Triangulation
1.6. Forecast Model 
1.7. USP’s of Report 
1.8. Report Description 
2. Chapter – Global Cancer Biological Therapy Market Overview: Qualitative Analysis
2.1. Market Introduction
2.2. Executive Summary 
2.3. Cancer Biological Therapy Market Classification
2.4. Market Drivers
2.5. Market Restraints
2.6. Market Opportunity
2.7. Cancer Biological Therapy Market: Trends
2.8. Porter’s Five Forces Analysis
2.8.1. Bargaining Power of Suppliers
2.8.2. Bargaining Power of Consumers
2.8.3. Threat of New Entrants
2.8.4. Threat of Substitute Product and Services
2.8.5. Competitive Rivalry within the Industry
2.9. Market Attractiveness Analysis 
2.9.1. Market Attractiveness Analysis by Segmentation 
2.9.2. Market Attractiveness Analysis by Region 
3. Chapter - Global Cancer Biological Therapy Market Overview: Quantitative Analysis
3.1. Cancer Biological Therapy Market Revenue (USD Million), Market Share (%) and Growth Rate (%), 2015 – 2025
4. Chapter –Cancer Biological Therapy Market Analysis: by Product Type
4.1. Cancer Biological Therapy Market Revenue (USD Million), by Product Type, 2015 – 2025
4.2. Cancer Biological Therapy Market Share (%), by Product Type, 2017
4.3. Cancer Biological Therapy Market Revenue Growth Rate (%), by Product Type, 2015 – 2025
5. Chapter –Cancer Biological Therapy Market Analysis: by Distribution Channel
5.1. Cancer Biological Therapy Market Revenue (USD Million), by Distribution Channel, 2015 – 2025
5.2. Cancer Biological Therapy Market Share (%), by Distribution Channel, 2017
5.3. Cancer Biological Therapy Market Revenue Growth Rate (%), by Distribution Channel, 2015 – 2025
6. Chapter - Cancer Biological Therapy Market Analysis: by Manufacturer 
6.1. Cancer Biological Therapy Market Revenue (USD Million), by Manufacturer, 2015 – 2025
6.2. Cancer Biological Therapy Market Share (%), by Manufacturer, 2017
6.3. Cancer Biological Therapy Market Revenue Growth Rate (%), by Manufacturer, 2015 – 2025
6.4. Merger & Acquisition
6.5. Collaborations and Partnership
6.6. New Product Launch
7. Chapter –Cancer Biological Therapy Market: Regional Analysis
7.1. North America
7.1.1. North America Cancer Biological Therapy Revenue (USD Million) and Growth Rate (%), 2015 – 2025.
7.1.2. North America Cancer Biological Therapy Market Revenue (USD Million) By Country, 2015 – 2025.
7.1.3. North America Cancer Biological Therapy Revenue Market Share (%) By Country, 2015 – 2025.
7.2. Europe
7.2.1. Europe Cancer Biological Therapy Revenue (USD Million) and Growth Rate (%), 2015 – 2025.
7.2.2. Europe Cancer Biological Therapy Market Revenue (USD Million) By Country, 2015 – 2025.
7.2.3. Europe Cancer Biological Therapy Revenue Market Share (%) By Country, 2015 – 2025.
7.3. Asia Pacific
7.3.1. Asia Pacific Cancer Biological Therapy Revenue (USD Million) and Growth Rate (%), 2015 – 2025.
7.3.2. Asia Pacific Cancer Biological Therapy Market Revenue (USD Million) By Country, 2015 – 2025.
7.3.3. Asia Pacific Cancer Biological Therapy Revenue Market Share (%) By Country, 2015 – 2025.
7.4. Latin America
7.4.1. Latin America Cancer Biological Therapy Revenue (USD Million) and Growth Rate (%), 2015 – 2025.
7.4.2. Latin America Cancer Biological Therapy Market Revenue (USD Million) By Country, 2015 – 2025.
7.4.3. Latin America Cancer Biological Therapy Revenue Market Share (%) By Country, 2015 – 2025.
7.5. Middle East & Africa
7.5.1. Middle East & Africa Cancer Biological Therapy Revenue (USD Million) and Growth Rate (%), 2015 – 2025.
7.5.2. Middle East & Africa Cancer Biological Therapy Market Revenue (USD Million) By Country, 2015 – 2025.
7.5.3. Middle East & Africa Cancer Biological Therapy Revenue Market Share (%) By Country, 2015 – 2025.
8. Chapter - Company Profiles
8.1. F. Hoffmann-La Roche AG
8.1.1. Overview
8.1.2. Financials
8.1.3. Product portfolio
8.1.4. F. Hoffmann-La Roche AG Total Company Sales 2015-2025 
8.1.5. F. Hoffmann-La Roche AG Total Company Sales, By Segment of Business 2015-2025
8.1.6. F. Hoffmann-La Roche AG Total Company Sales, By Region 2015-2025 
8.1.7. Business strategy
8.1.8. Recent developments
8.2. Novartis International AG
8.3. Merck & Co., Inc.
8.4. Amgen Inc.
8.5. GlaxoSmithKline Plc
8.6. Bristol-Myers Squibb
8.7. Eli Lilly
8.8. Spectrum Pharmaceuticals, Inc.
8.9. Seattle Genetics, Inc.
8.10. Celgene Corporation
8.11. Others
9. Chapter – Market Research and Findings
This free Sample Report is purely a representation of our full report, for evaluating the market scope/data and make informed purchase decisions.